Cargando…
Evaluation of Molecular Simulations and Deep Learning Prediction of Antibodies’ Recognition of TRBC1 and TRBC2
T cell receptor β-chain constant (TRBC) is a promising class of cancer targets consisting of two highly homologous proteins, TRBC1 and TRBC2. Developing targeted antibody therapeutics against TRBC1 or TRBC2 is expected to eradicate the malignant T cells and preserve half of the normal T cells. Recen...
Autores principales: | Zeng, Xincheng, Wang, Tianqun, Kang, Yue, Bai, Ganggang, Ma, Buyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525649/ https://www.ncbi.nlm.nih.gov/pubmed/37753972 http://dx.doi.org/10.3390/antib12030058 |
Ejemplares similares
-
Computational discovery of binding mode of anti-TRBC1 antibody and predicted key amino acids of TRBC1
por: Saetang, Jirakrit, et al.
Publicado: (2022) -
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies
por: Zhang, Chaoting, et al.
Publicado: (2020) -
PD-1 combined with TRBC1 and pan-T cell antibodies for robustly monitoring angioimmunoblastic T-cell lymphoma
por: Wang, Chunyan, et al.
Publicado: (2022) -
Anti-TRBC1 Antibody-Based Flow Cytometric Detection of T-Cell Clonality: Standardization of Sample Preparation and Diagnostic Implementation
por: Muñoz-García, Noemí, et al.
Publicado: (2021) -
TRBC1在成熟T细胞淋巴瘤中的表达特点及诊断价值
Publicado: (2022)